Skip to main content

Table 1 The baseline data of the patients with CAP

From: Efficacy of the quick sequential organ failure assessment for predicting clinical outcomes among community-acquired pneumonia patients presenting in the emergency department

CharacteristicsICU
(n = 174)
Non-ICU
(n = 568)
PARDS
(n = 164)
Non-ARDS (n = 578)PSurvivor
(n = 443)
Non-Survivors (n = 299)P
Age, years70.40 ± 13.4668.60 ± 13.740.12870.26 ± 14.1968.67 ± 13.530.18968.23 ± 13.5070.19 ± 13.900.055
Male, %106 (60.92)356 (62.68)0.676100 (60.98)362 (62.63)0.670268 (60.50)194 (64.88)0.227
COPD, %56 (32.18)121 (21.30)0.00346 (28.05)131 (22.66)0.15390 (20.32)87 (29.10)0.006
CVD, %39 (22.41)91 (16.02)0.05234 (20.73)96 (16.61)0.22078 (17.61)52 (17.39)0.940
Hypertension, %89 (51.15)254 (44.72)0.13779 (48.17)264 (45.67)0.572205 (46.28)138 (46.15)0.974
DM, %68 (39.08)190 (33.45)0.17365 (39.63)193 (33.39)0.138136 (30.70)122 (40.80)0.005
CHF, %86 (49.43)236 (41.55)0.06772 (43.90)250 (43.25)0.882180 (40.63)142 (47.49)0.064
CRD, %27 (15.52)57 (10.04)0.04620 (12.20)64 (11.07)0.68946 (10.38)38 (12.71)0.327
Tumor, %23 (13.22)55 (9.68)0.18324 (14.63)54 (9.34)0.05135 (7.90)43 (14.38)0.005
MBP, mmHg81.91 ± 24.1992.33 ± 18.88< 0.00182.34 ± 23.9992.02 ± 19.16< 0.00192.15 ± 19.8386.53 ± 21.54< 0.001
Respiratory rate, beats/min31.95 ± 7.3329.72 ± 6.46< 0.00132.15 ± 8.3029.70 ± 6.13< 0.00129.91 ± 6.2730.74 ± 7.370.110
Temperature, °C37.48 ± 1.3037.41 ± 1.130.53537.69 ± 1.3637.35 ± 1.100.00437.46 ± 1.1437.37 ± 1.220.305
Heart rate, beats/min78.11 ± 21.31107.20 ± 31.20< 0.001116.60 ± 21.69111.70 ± 29.410.079109.30 ± 21.25115.00 ± 29.640.002
PaO2, mmHg73.54 ± 34.7884.15 ± 31.45< 0.00166.49 ± 29.1785.97 ± 32.19< 0.00181.92 ± 28.8981.29 ± 37.370.804
Lac, mmol/L4.47 ± 3.692.07 ± 2.05< 0.0012.60 (1.50,5.05)1.50 (0.90,2.50)< 0.0011.50 (1.00,2.40)2.00 (1.10,4.20)< 0.001
PCT, ng/mL1.50 (0.28,8.50)0.28 (0.06,1.75)< 0.0011.62 (0.35,9.53)0.27 (0.06,1.68)< 0.0010.24 (0.06,1.44)1.06 (0.16,6.16)< 0.001
WBC, ×109/L12.77 (8.23,18.97)11.22 (7.99,15.66)< 0.00112.70 (7.73,17.67)11.34 (8.11,15.88)0.22912.30 (8.38,16.82)12.30 (7.80,15.88)0.111
PaO2/FiO2199.70 ± 105.10246.20 ± 104.50< 0.001165.40 ± 71.61255.20 ± 4.42< 0.001239.08 ± 96.05229.76 ± 120.050.262
CRP42.39 ± 5.2541.59 ± 5.060.03743.09 ± 5.3041.58 ± 5.06< 0.00141.59 ± 5.0642.39 ± 5.250.037
qSOFA score1.96 ± 0.761.35 ± 0.62< 0.0011.98 ± 0.701.36 ± 0.64< 0.0011.38 ± 0.631.66 ± 0.77< 0.001
SOFA score9.58 ± 5.115.38 ± 4.18< 0.0019.21 ± 4.855.56 ± 4.41< 0.0015.66 ± 4.087.40 ± 5.45< 0.001
CURB-65 score3.16 ± 1.232.19 ± 1.19< 0.0013.29 ± 1.172.17 ± 1.18< 0.0012.22 ± 1.202.71 ± 1.30< 0.001
  1. COPD chronic obstructive pulmonary disease, CVD Cerebrovascular disease, DM Diabetes mellitus, CHF chronic heart failure, CRD chronic renal dysfunction, MBP myelin basic protein, Lac lactate, PCT: p rocalcitonin, WBC white blood cell, CRP C-reactive protein, qSOFA quick sequential organ failure assessment, SOFA sequential organ failure assessment, CURB-65 confusion, urea, respiratory rate, blood pressure and age